loadpatents
Patent applications and USPTO patent grants for Forgione; Pasquale.The latest application filed is for "thienoisoquinolines and their derivatives for targeting tubulin, ch-tog, aurora a kinase, tpx2, cdk5rap2 and/or aspm".
Patent | Date |
---|---|
Thienoisoquinolines and their derivatives for the treatment of cancer Grant 11,034,702 - Forgione , et al. June 15, 2 | 2021-06-15 |
Thienoisoquinolines And Their Derivatives For Targeting Tubulin, Ch-tog, Aurora A Kinase, Tpx2, Cdk5rap2 And/or Aspm App 20200276181 - FORGIONE; Pasquale ;   et al. | 2020-09-03 |
Thienoisoquinolines And Their Derivatives For The Treatment Of Cancer App 20200024284 - FORGIONE; Pasquale ;   et al. | 2020-01-23 |
Viral polymerase inhibitors Grant 8,912,182 - Beaulieu , et al. December 16, 2 | 2014-12-16 |
Viral Polymerase Inhibitors App 20130331391 - BEAULIEU; Pierre L. ;   et al. | 2013-12-12 |
Viral polymerase inhibitors Grant 8,541,402 - Beaulieu , et al. September 24, 2 | 2013-09-24 |
Viral polymerase inhibitors Grant 8,476,257 - Beaulieu , et al. July 2, 2 | 2013-07-02 |
Hepatitis C Inhibitor Compounds App 20120269769 - LLINAS-BRUNET; Montse ;   et al. | 2012-10-25 |
Viral Polymerase Inhibitors App 20120214783 - BEAULIEU; Pierre L. ;   et al. | 2012-08-23 |
Viral Polymerase Inhibitors App 20120101091 - Beaulieu; Pierre ;   et al. | 2012-04-26 |
Hepatitis C Inhibitor Compounds App 20120034187 - LLINAS-BRUNET; Montse ;   et al. | 2012-02-09 |
Hepatitis C inhibitor compounds Grant 8,067,438 - Llinas-Brunet , et al. November 29, 2 | 2011-11-29 |
Viral Polymerase Inhibitors App 20110230465 - STAMMERS; Timothy ;   et al. | 2011-09-22 |
Hepatitis C Inhibitor Compounds App 20110177030 - LLINAS-BRUNET; Montse ;   et al. | 2011-07-21 |
Hepatitis C inhibitor compounds Grant 7,939,667 - Llinas-Brunet , et al. May 10, 2 | 2011-05-10 |
Viral Polymerase Inhibitors App 20110021486 - Beaulieu; Pierre L. ;   et al. | 2011-01-27 |
Viral Polymerase Inhibitors App 20100286131 - Beaulieu; Pierre L. ;   et al. | 2010-11-11 |
Macrocyclic peptides active against the hepatitis C virus Grant 7,749,961 - Llinas-Brunet , et al. July 6, 2 | 2010-07-06 |
Hepatitis C inhibitor peptide analogs Grant 7,705,146 - Bailey , et al. April 27, 2 | 2010-04-27 |
Inhibitors of Hepatitis C NS3 Protease App 20100087382 - Bailey; Murray D. ;   et al. | 2010-04-08 |
Macrocyclic Peptides Active Against The Hepatitis C Virus App 20100028300 - LLINAS-BRUNET; Montse ;   et al. | 2010-02-04 |
Macrocyclic Peptides Active Against The Hepatitis C Virus App 20090264346 - LLINAS-BRUNET; Montse ;   et al. | 2009-10-22 |
Hepatitis C inhibitor compounds Grant 7,585,845 - Llinas-Brunet , et al. September 8, 2 | 2009-09-08 |
Hepatitis C Inhibitor Peptide Analogs App 20080200497 - Bailey; Murray D. ;   et al. | 2008-08-21 |
Hepatitis C Inhibitor Compounds App 20070243166 - LLINAS-BRUNET; Montse ;   et al. | 2007-10-18 |
Hepatitis c inhibitor peptide analogs App 20060258868 - Bailey; Murray D. ;   et al. | 2006-11-16 |
Macrocyclic peptides active against the hepatitis C virus App 20050192212 - Llinas-Brunet, Montse ;   et al. | 2005-09-01 |
Macrocyclic peptides active against the hepatitis C virus App 20050080005 - Llinas-Brunet, Montse ;   et al. | 2005-04-14 |
Hepatitis C inhibitor compounds App 20050020503 - Llinas-Brunet, Montse ;   et al. | 2005-01-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.